#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13444	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2216	602.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1681	1681	T	694	T,C	649,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13444	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2216	602.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	793	C,G	737,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24878	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	698.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1647	1647	A	852	A	792	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24878	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	698.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2281	2281	C	831	C,T	777,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24878	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	698.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2355	2355	A	783	A	751	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24878	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	698.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2907	2907	C	786	C	756	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1992	folP	855	855	100.0	folP.l6.c30.ctg.1	1621	122.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1033	1035	AGC	197;202;201	A;G,T;C	190;192,1;190	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5084	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3483	145.5	1	SNP	p	S91F	1	.	.	271	273	TTC	552	554	TTC	148;148;150	T;T;C	136;137;136	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5084	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3483	145.5	1	SNP	p	D95G	1	.	.	283	285	GGC	564	566	GGC	152;153;153	G;G;C	139;139;140	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5084	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3483	145.5	1	SNP	p	G95N	0	.	.	283	285	GGC	564	566	GGC	152;153;153	G;G;C	139;139;140	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1634	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1366	119.1	1	SNP	p	G45D	0	.	.	133	135	GGC	430	432	GGC	202;205;205	G;G,T;C	191;192,1;193	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	810	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1026	78.4	0	.	n	.	0	A197.	DEL	197	197	A	657	657	A	203	A	189	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3066	159.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1576	1578	GTC	192;195;190	G;T;C	178;180;178	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3066	159.9	1	SNP	p	D86N	0	.	.	256	258	GAC	682	684	GAC	195;198;198	G;A;C	174;166;175	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3066	159.9	1	SNP	p	R87W	0	.	.	259	261	CGT	685	687	CGT	194;192;193	C,A;G;T	171,1;176;172	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3066	159.9	1	SNP	p	S87R	1	.	.	259	261	CGT	685	687	CGT	194;192;193	C,A;G;T	171,1;176;172	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3066	159.9	1	SNP	p	R87I	0	.	.	259	261	CGT	685	687	CGT	194;192;193	C,A;G;T	171,1;176;172	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3066	159.9	1	SNP	p	S88P	0	.	.	262	264	TCC	688	690	TCC	195;197;194	T;C;C	173;177;175	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4248	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2685	157.6	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1273	1275	TGC	184;183;180	T;G;C	169;171;170	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4248	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2685	157.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1483	1485	GGC	221;222;224	G;G;C	207;206;207	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1236	1238	GCA	207;211;212	G;C;A	194;196;200	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1239	1241	ATC	218;219;219	A;T;C	204;200;201	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1251	1253	GTG	227;228;229	G;T,C;G	210;210,1;210	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1251	1253	GTG	227;228;229	G;T,C;G	210;210,1;210	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1755	1757	ACC	212;212;210	A;C;C	186;187;188	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1809	1811	GCG	192;191;187	G;C;G	171;153;159	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1809	1811	GCG	192;191;187	G;C;G	171;153;159	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1932	1934	GGC	188;188;190	G;G,T;C	173;171,1;172	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1941	1943	GGC	192;192;191	G;G;C,T	170;173;172,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3960	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2341	168.4	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1959	1961	TCG	176;176;173	T,G;C;G	112,9;134;137	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5194	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3096	167.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1573	1575	CCG	200;202;204	C;C;G,A	183;189;183,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2144	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1646	129.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	485	485	C	158	C	140	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	112	91.96	porB1a.l15.c17.ctg.1	489	30.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	349	351	ACG	70;69;68	A;C;G	65;64;63	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	112	91.96	porB1a.l15.c17.ctg.1	489	30.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	391	393	CAA	31;29;27	C;A;A	29;27;25	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	112	91.96	porB1a.l15.c17.ctg.1	489	30.6	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	397	399	TAC	20;19;19	T;A;C	20;19;19	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	400	402	GAA	199;203;202	G;A;A	185;188;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	688	690	GAT	225;228;225	G;A;T	207;210;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	811	813	TCA	216;219;218	T;C,A;A	199;200,1;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	940	942	GTC	212;214;213	G;T;C	197;197;198	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1270	1272	GCA	178;178;179	G;C;A	170;169;169	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	1	SNP	p	G120K	1	.	.	358	360	AAG	646	648	AAG	216;217;217	A;A;G	200;200;197	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	1	SNP	p	A121D	1	.	.	361	363	GAC	649	651	GAC	215;213;215	G;A,G;C	196;195,1;198	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2546	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1479	171.0	1	SNP	p	D121N	0	.	.	361	363	GAC	649	651	GAC	215;213;215	G;A,G;C	196;195,1;198	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9634	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4956	193.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2043	2045	AAT	213;214;218	A;A;T	197;198;200	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1038	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	821	124.3	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	218;219;217	A;T;G	207;207;207	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
